Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Zidovudine |
Click to Show/Hide the Detail |
Drug ID |
DR1729
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella aerofaciens co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Dopamine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0532
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Dopamine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [12] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
Drug ID |
DR0476
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [14] |
Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [16] |
Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [18], [19] |
Testosterone cypionate |
Click to Show/Hide the Detail |
Drug ID |
DR1564
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [21], [18] |
Bacteria: Bacteroidetes |
Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Cyclophosphamide |
Click to Show/Hide the Detail |
Drug ID |
DR0391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Alloprevotella tannerae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alloprevotella tannerae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [26] |
Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides caccae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides caccae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Glipizide |
Click to Show/Hide the Detail |
Drug ID |
DR0778
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 20 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Doxazosin |
Click to Show/Hide the Detail |
Drug ID |
DR0542
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Gliclazide |
Click to Show/Hide the Detail |
Drug ID |
DR0776
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
Glipizide |
Click to Show/Hide the Detail |
Drug ID |
DR0778
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Methsuximide |
Click to Show/Hide the Detail |
Drug ID |
DR1050
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Methsuximide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Phenytoin |
Click to Show/Hide the Detail |
Drug ID |
DR1282
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1679
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [37] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides finegoldii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides finegoldii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides finegoldii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 19 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Cyclophosphamide |
Click to Show/Hide the Detail |
Drug ID |
DR0391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Gliclazide |
Click to Show/Hide the Detail |
Drug ID |
DR0776
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
Glipizide |
Click to Show/Hide the Detail |
Drug ID |
DR0778
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lofexidine |
Click to Show/Hide the Detail |
Drug ID |
DR0967
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Lofexidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Naftopidil |
Click to Show/Hide the Detail |
Drug ID |
DR1124
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Naftopidil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Warfarin sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1717
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides oleiciplenus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides oleiciplenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [41] |
Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Phenytoin |
Click to Show/Hide the Detail |
Drug ID |
DR1282
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1679
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1679
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Gliclazide |
Click to Show/Hide the Detail |
Drug ID |
DR0776
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 18 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27], [42] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Gliclazide |
Click to Show/Hide the Detail |
Drug ID |
DR0776
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Bacteroides vulgatus further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Phenytoin |
Click to Show/Hide the Detail |
Drug ID |
DR1282
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1679
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
Verapamil hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1681
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[44], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Warfarin sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1717
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Phenytoin |
Click to Show/Hide the Detail |
Drug ID |
DR1282
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Capnocytophaga gingivalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga gingivalis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
Capnocytophaga granulosa (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga granulosa co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
Capnocytophaga haemolytica (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga haemolytica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Capnocytophaga leadbetteri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga leadbetteri co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
Capnocytophaga ochracea (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga ochracea co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
Capnocytophaga sputigena (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga sputigena co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Gliclazide |
Click to Show/Hide the Detail |
Drug ID |
DR0776
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
Glipizide |
Click to Show/Hide the Detail |
Drug ID |
DR0778
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [49] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Gliclazide |
Click to Show/Hide the Detail |
Drug ID |
DR0776
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Phenytoin |
Click to Show/Hide the Detail |
Drug ID |
DR1282
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Voriconazole |
Click to Show/Hide the Detail |
Drug ID |
DR1709
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Prevotella bivia (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella bivia co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
Prevotella buccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella buccae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [50] |
Aspirin |
Click to Show/Hide the Detail |
Drug ID |
DR1749
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Prevotella denticola (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella denticola co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Prevotella intermedia (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella intermedia co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [26] |
Prevotella loescheii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella loescheii co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Prevotella melaninogenica (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella melaninogenica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46], [53] |
Prevotella nigrescens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella nigrescens co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [26], [46] |
Prevotella oralis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella oralis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
Prevotella veroralis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella veroralis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Bacteria: Firmicutes |
Acidaminococcus fermentans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Acidaminococcus fermentans co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [54] |
Acidaminococcus intestini (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Acidaminococcus intestini co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [55] |
Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Zidovudine |
Click to Show/Hide the Detail |
Drug ID |
DR1729
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerostipes hadrus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerostipes hadrus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerotruncus colihominis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerotruncus colihominis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
Drug ID |
DR0476
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [56] |
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [57] |
Progesterone |
Click to Show/Hide the Detail |
Drug ID |
DR1346
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [58] |
Propranolol hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1367
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Propranolol hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [58] |
Testosterone cypionate |
Click to Show/Hide the Detail |
Drug ID |
DR1564
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [58], [60] |
Bacillus pumilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus pumilus co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [62] |
Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Cyclophosphamide |
Click to Show/Hide the Detail |
Drug ID |
DR0391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Doxazosin |
Click to Show/Hide the Detail |
Drug ID |
DR0542
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ramelteon |
Click to Show/Hide the Detail |
Drug ID |
DR1391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Sildenafil citrate |
Click to Show/Hide the Detail |
Drug ID |
DR1481
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia luti co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia luti co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Sildenafil citrate |
Click to Show/Hide the Detail |
Drug ID |
DR1481
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
Carisoprodol |
Click to Show/Hide the Detail |
Drug ID |
DR0277
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Doxazosin |
Click to Show/Hide the Detail |
Drug ID |
DR0542
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Methsuximide |
Click to Show/Hide the Detail |
Drug ID |
DR1050
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Methsuximide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Paroxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1245
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Paroxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
Sildenafil citrate |
Click to Show/Hide the Detail |
Drug ID |
DR1481
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium scindens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium scindens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
Clopidogrel bisulfate |
Click to Show/Hide the Detail |
Drug ID |
DR0355
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Vilazodone hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1687
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
Zonisamide |
Click to Show/Hide the Detail |
Drug ID |
DR1737
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Zonisamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [66] |
Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium symbiosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium symbiosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Coprococcus comes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Coprococcus comes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Erysipelatoclostridium ramosum further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelatoclostridium ramosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelatoclostridium ramosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Erysipelothrix rhusiopathiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelothrix rhusiopathiae co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [67], [68] |
Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium rectale co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium rectale co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Cyclophosphamide |
Click to Show/Hide the Detail |
Drug ID |
DR0391
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Glipizide |
Click to Show/Hide the Detail |
Drug ID |
DR0778
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Jeotgalicoccus psychrophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Aspirin |
Click to Show/Hide the Detail |
Drug ID |
DR1749
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Jeotgalicoccus psychrophilus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Lactobacillus reuteri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Lactobacillus reuteri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Marvinbryantia formatexigens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Marvinbryantia formatexigens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Peptostreptococcus anaerobius (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Peptostreptococcus anaerobius co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Pseudoflavonifractor capillosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Pseudoflavonifractor capillosus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [69] |
Roseburia hominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Roseburia hominis further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Roseburia intestinalis further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Ruminococcus albus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Aspirin |
Click to Show/Hide the Detail |
Drug ID |
DR1749
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus albus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus torques co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus torques co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus torques co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Subdoligranulum variabile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Subdoligranulum variabile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Bacteria: Fusobacteria |
Fusobacterium mortiferum (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Fusobacterium mortiferum co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Fusobacterium varium co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Bacteria: Lentisphaerae |
Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Diltiazem hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0509
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Bacteria: Proteobacteria |
Achromobacter xylosoxidans (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Achromobacter xylosoxidans co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [70] |
Acidovorax ebreus (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Acidovorax ebreus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [71] |
Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Citrobacter freundii co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Edwardsiella tarda co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Edwardsiella tarda co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [62] |
Flunitrazepam |
Click to Show/Hide the Detail |
Drug ID |
DR0712
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Flunitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [73] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Indomethacin |
Click to Show/Hide the Detail |
Drug ID |
DR0875
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Escherichia coli further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [74] |
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Helicobacter apodemus (epsilon-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Aspirin |
Click to Show/Hide the Detail |
Drug ID |
DR1749
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Helicobacter apodemus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
Klebsiella aerogenes (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Klebsiella aerogenes co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [70] |
Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Klebsiella pneumoniae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [70] |
Neisseria sicca (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Neisseria sicca co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
Photorhabdus asymbiotica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Photorhabdus asymbiotica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [75], [76] |
Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [62] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia alcalifaciens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia alcalifaciens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia rettgeri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia rettgeri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Terbinafine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1557
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Nicotine |
Click to Show/Hide the Detail |
Drug ID |
DR1148
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [78] |
Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [79] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Shigella sonnei (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Amoxicillin |
Click to Show/Hide the Detail |
Drug ID |
DR0104
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Shigella sonnei co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [80] |
Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ibuprofen |
Click to Show/Hide the Detail |
Drug ID |
DR0844
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [81] |
Bacteria: Verrucomicrobia |
Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Naftopidil |
Click to Show/Hide the Detail |
Drug ID |
DR1124
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Akkermansia muciniphila co-metabolize the drug Naftopidil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [2] |
Omeprazole |
Click to Show/Hide the Detail |
Drug ID |
DR1196
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Akkermansia muciniphila co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Pantoprazole sodium |
Click to Show/Hide the Detail |
Drug ID |
DR1236
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Akkermansia muciniphila co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Archaea: Euryarchaeota |
Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter oralis co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [82] |
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter smithii co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [82] |
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Chloramphenicol |
Click to Show/Hide the Detail |
Drug ID |
DR0298
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanomassiliicoccus luminyensis co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [82] |
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
|
|
|
|
|
|